左氧氟沙星、环丙沙星......氟喹诺酮类竟可引发主动脉夹层？
但是，氟喹诺酮类还会引起主动脉瘤/夹层！
引起动脉瘤/夹层的机理是什么？
主动脉瘤/夹层有何危害？
哪些人群应避免使用？
临床还能用吗？
总结
氟喹诺酮类抗菌谱广，是临床常用的抗菌药物；
氟喹诺酮类可导致罕见但严重的不良反应：主动脉瘤/夹层；
主动脉瘤、老年患者等高风险人群应尽量避免使用氟喹诺酮类；
处方抗生素应权衡利弊，严格掌握适应证与禁忌证。
参考资料：
1. Hicks LA, Taylor TH, Hunkler RJ. U.S.outpatient antibiotic prescribing, 2010. N Engl J Med 2013;368:1461–2.doi: 10.1056/NEJMc1212055.
2. HicksLA, Bartoces MG, Roberts RM, Suda KJ, Hunkler RJ, Taylor TH, et al. USoutpatient antibiotic prescribing variation according to geography, patientpopulation, and provider specialty in 2011. Clin Infect Dis 2015;60:1308–16.doi: 10.1093/cid/civ076.
3. 杨宝峰, 陈建国. 药理学[M]. 第九版. 人民卫生出版社, 2018.
4. US Food and Drug Administration. FDA warns about increased risk of ruptures ortears in the aorta blood vessel with fluoroquinolone antibiotics in certainpatients. Published 2018. Accessed August 1, 2021.https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics.
5. LeeC-C, Lee M-TG, Chen Y-S, Lee S-H, Chen Y-S, Chen S-C, et al. Risk ofAortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.JAMA Intern Med 2015;175:1839–47. doi:10.1001/jamainternmed.2015.5389.
6. DanemanN, Lu H, Redelmeier DA. Fluoroquinolones and collagen associated severe adverseevents: a longitudinal cohort study. BMJ Open 2015;5:e010077. doi:10.1136/bmjopen-2015-010077.
7. PasternakB, Inghammar M, Svanström H. Fluoroquinolone use and risk ofaortic aneurysm and dissection: nationwide cohort study. BMJ 2018;360:k678.doi: 10.1136/bmj.k678.
8. LeeC-C, Lee M-TG, Hsieh R, Porta L, Lee W-C, Lee S-H, et al. OralFluoroquinolone and the Risk of AorticDissection. J Am Coll Cardiol 2018;72:1369–78.doi: 10.1016/j.jacc.2018.06.067.
9. NewtonER, Akerman AW, Strassle PD, Kibbe MR. Association of Fluoroquinolone Use WithShort-term Risk of Development of Aortic Aneurysm. JAMA Surg 2021;156:264–72.doi: 10.1001/jamasurg.2020.6165.
10. WeeI, Chin B, Syn N, Lee KS, Ng JJ, Choong AMTL. The association betweenfluoroquinolones and aortic dissection and aortic aneurysms: a systematicreview and meta-analysis. Sci Rep 2021;11:11073. doi:10.1038/s41598-021-90692-8.
11. KarthikesalingamA, Holt PJ, Vidal-Diez A, Ozdemir BA, Poloniecki JD, Hinchliffe RJ, et al.Mortality from ruptured abdominal aortic aneurysms: clinical lessons from acomparison of outcomes in England and the USA. Lancet 2014;383:963–9.doi: 10.1016/S0140-6736(14)60109-4.
12. GillumRF. Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol1995;48:1289–98. doi: 10.1016/0895-4356(95)00045-3.
13. FilipovicM, Goldacre MJ, Roberts SE, Yeates D, Duncan ME, Cook-Mozaffari P. Trends inmortality and hospital admission rates for abdominal aortic aneurysm in Englandand Wales, 1979-1999. Br J Surg 2005;92:968–75.doi: 10.1002/bjs.5118.
14. LilienfeldDE, Gunderson PD, Sprafka JM, Vargas C. Epidemiology of aortic aneurysms: I.Mortality trends in the United States, 1951 to 1981. Arteriosclerosis1987;7:637–43. doi: 10.1161/01.atv.7.6.637.
15. HuYH, Shimizu H, Kawakami N, Takatsuka N, Ido M, Hirose H. Increasing trends inmortality rate of aortic aneurysms in Japan, 1955-90. Tohoku J Exp Med1993;171:221–8. doi: 10.1620/tjem.171.221.
16. SampsonUKA, Norman PE, Fowkes FGR, Aboyans V, Yanna Song null, Harrell FE, et al. Global andregional burden of aortic dissection and aneurysms: mortality trends in 21world regions, 1990 to 2010. Glob Heart 2014;9:171-180.e10. doi:10.1016/j.gheart.2013.12.010.
17. SidloffD, Choke E, Stather P, Bown M, Thompson J, Sayers R. Mortality from thoracicaortic diseases and associations with cardiovascular risk factors. Circulation2014;130:2287–94. doi:10.1161/CIRCULATIONAHA.114.010890.